BioHealth News Archive

NIH Technology Accelerator Challenge (NTAC) | National Institute of Biomedical Imaging and Bioengineering

NIH Technology Accelerator Challenge (NTAC) | National Institute of Biomedical Imaging and Bioengineering

Prize Competition for Maternal Health NIBIB launched the NIH Technology Accelerator Challenge (NTAC) series of prize competitions to stimulate the design of new diagnostic…

Read More
Structural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development | Immunology | Frontiers

Structural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development | Immunology | Frontiers

Monoclonal antibodies (mAbs) have proven effective for the treatment of ebolavirus infection in humans, with two mAb-based drugs Inmazeb™ and Ebanga™ receiving FDA approval…

Read More
JHU revises COVID-19 safety protocols ahead of spring semester | Hub

JHU revises COVID-19 safety protocols ahead of spring semester | Hub

Johns Hopkins University is revising its safety protocols ahead of the start of the spring semester as it prepares to resume a broad range…

Read More
One Of America’s Richest Self-Made Women, Martine Rothblatt, Played Key Role In Week’s Historic Heart Transplant

One Of America’s Richest Self-Made Women, Martine Rothblatt, Played Key Role In Week’s Historic Heart Transplant

When the University of Maryland Medical Center announced the first successful transplant of a heart that was grown in a genetically altered pig earlier…

Read More
First pig-to-human heart transplant: what can scientists learn?

First pig-to-human heart transplant: what can scientists learn?

The first person to receive a transplanted heart from a genetically modified pig is doing well after the procedure last week in Baltimore, Maryland.…

Read More
Founder and Executive Chairman of Emergent BioSolutions Announces Retirement

Founder and Executive Chairman of Emergent BioSolutions Announces Retirement

GAITHERSBURG, Md., Jan. 14, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that Fuad El-Hibri, founder and executive chairman, has decided…

Read More
BioSpace: Cartesian Aims to Propel RNA Cell Therapy with Combinations

BioSpace: Cartesian Aims to Propel RNA Cell Therapy with Combinations

Published: Jan 07, 2022 By Gail Dutton   Cartesian Therapeutics is developing non-permanent cell therapies that can be used soon after diagnosis and address…

Read More
Institute for Bioscience and Biotechnology Research Receives $16.8M Investment from the National Institute of Standards and Technology

Institute for Bioscience and Biotechnology Research Receives $16.8M Investment from the National Institute of Standards and Technology

Fri, Jan 14, 2022   New Cooperative Agreement to Aid in the Development of Therapeutics and Vaccines, Improve Access to Medication   The Institute…

Read More
Unblock research bottlenecks with non-profit start-ups

Unblock research bottlenecks with non-profit start-ups

It takes more than a great idea to accomplish a great project. Our research and experience have convinced us that many worthy projects wither…

Read More

Cartesian Aims to Propel RNA Cell Therapy with Combinations | BioSpace

Cartesian Therapeutics is developing non-permanent cell therapies that can be used soon after diagnosis and address a wide range of diseases beyond cancer. The…

Read More
South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine – Jan 12, 2022

South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine – Jan 12, 2022

-- Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) is the first protein-based COVID-19 vaccine granted approval in South Korea GAITHERSBURG, Md., Jan. 12, 2022 /PRNewswire/ --…

Read More
Chain Drug Review Pharmacy Outlook: Ronald Piervincenzi, USP

Chain Drug Review Pharmacy Outlook: Ronald Piervincenzi, USP

January 10, 2022 by Ronald Piervincenzi   The COVID-19 pandemic made the last year both an extraordinary and challenging time to work in health care.…

Read More
Decentralized Clinical Trials Raise Concerns About Informed Consent

Decentralized Clinical Trials Raise Concerns About Informed Consent

Under pressure of the COVID-19 pandemic, multitudes of clinical trials of new medications and treatments have moved to a decentralized model, bringing them to…

Read More
REGENXBIO Announces Initiation of Second Pivotal Trial in RGX-314 Clinical Program for the Treatment of Wet AMD Using Subre…

REGENXBIO Announces Initiation of Second Pivotal Trial in RGX-314 Clinical Program for the Treatment of Wet AMD Using Subre…

ROCKVILLE, Md., Jan. 10, 2022 /PRNewswire/ -- ASCENTTM, a Phase III clinical trial conducted in partnership with AbbVie, is expected to enroll patients in…

Read More
MIMETAS opens Phenotypic Screening Center

MIMETAS opens Phenotypic Screening Center

Leiden, May 27, 2021 - MIMETAS, the global leader in human-relevant organ-on-a-chip models, has just opened their Phenotypic Screening Center. The center facilitates large-scale…

Read More